© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to May
monovalent degrader + full antagonist of ER_
orally efficacious in xenograft model
from ligand-based design of full antag.
ACS Med. Chem. Lett., May 29, 2020
Genentech, South San Francisco, CA
GNE-149 is an efficient monovalent degrader and full antagonist of estrogen receptor alpha with significant oral bioavailability in higher species. The standard-of-care selective ER degrader (SERD) fulvestrant is not orally…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.